Antibody-directed photodynamic therapy of methicillin-resistant Staphylococcus aureus

Microbial Drug Resistance

Volumn 10, Issue 2, 2004, Pages 92-97

  Embleton, Michelle L ^a   Nair, Sean P ^a   Cookson, Barry D ^b   Wilson, Michael ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G TIN CHLORIN E6 CONJUGATE; PHOTOSENSITIZING AGENT; TIN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BACTERICIDAL ACTIVITY; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG CONJUGATION; ESCHERICHIA COLI; LASER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; RED LIGHT;

GREAT BRITAIN; HUMANS; IMMUNOGLOBULIN G; METHICILLIN RESISTANCE; PHOTOCHEMOTHERAPY; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ESCHERICHIA COLI; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 3042736048     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/1076629041310000     Document Type: Article

References (33)

1. Centers for Disease Control and Prevention. 1999. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. J. Am. Med. Assn. 282:1123-1125.
2. 2003. Outbreaks of community-associated methicillin-resistant Staphyloccus aureus skin infections-Los Angeles County, California, 2002-2003. Morb Mortal Wkly Rep. 52:88.
3. Ackroyd, R., C. Kelty, N. Brown, and M. Reed. 2001. The history of photodetection and photodynamic therapy. Photochem. Photobiol. 74:656-669.
4. Ayliffe, G.A.J., M.S.C. Casewell, and B.D. Cookson. 1998. Report of a combined working party of Brit Soc Antimicrob Chemother Hospital Infect Soc & Infection Control Nurses' Assoc. J Hosp Infect. 39:253-290.
5. Berthiaume, F., S.R. Reiken, M. Toner, R.G. Tompkins, and M.L. Yarmush. 1994. Antibody-targeted photolysis of bacteria in vivo. Biotechnology (N. Y.). 12:703-706.
6. Bertoloni, G., F.M. Lauro, G. Cortella, and M. Merchat. 2000. Photosensitizing activity of hematoporphyrin on Staphylococcus aureus cells. Biochim. Biophys. Acta 1475:169-174.
7. Bhatti, M., A. MacRobert, B. Henderson, P. Shepherd, J. Cridland, and M. Wilson. 2000. Antibody-targeted lethal photosensitization of Porphyromonas gingivalis. Antimicrob. Agents Chemother. 44:2615-2618.
8. Bhatti, M., A. MacRobert, S. Meghji, B. Henderson, and M. Wilson. 1997. Effect of dosimetric and physiological factors on the lethal photosensitization of Porphyromonas gingivalis in vitro. Photochem. Photobiol. 65:1026-1031.
9. Bhatti, M., A. MacRobert, S. Meghji, B. Henderson, and M. Wilson. 1998. A study of the uptake of toluidine blue O by Porphyromonas gingivalis and the mechanism of lethal photosensitization. Photochem. Photobiol. 68:370-376.
10. Bierbaum, G., K. Fuchs, W. Lenz, C. Szekat, and H.G. Sahl. 1999. Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany. Eur. J Clin. Microbiol. Infect. Dis. 18:691-696.
11. Blake, J.E., and M.A. Metcalfe. 2001. A shared noncapsular antigen is responsible for false-positive reactions by Staphylococcus epidermidis in commercial agglutination tests for Staphylococcus aureus. J. Clin. Microbiol. 39:544-550.
12. Embleton, M.L., S.P. Nair, B.D. Cookson, and M. Wilson. 2002. Selective lethal photosensitization of methicillin-resistant Staphylococcus aureus using an IgG-tin (IV) chlorin e6 conjugate. J. Antimicrob. Chemother. 50:857-864.
13. Forsgren, A., V. Ghetie, R. Lindmark, and J. Sjoquist. 1983. Protein A and its exploitation. In C.S.F. Easman and C. Adlam (eds.), Staphylococci and staphylococcal infections 2. Academic Press, London, pp. 429-479.
14. González-Zorn, B., and P. Courvalin. 2003. vanA-mediated high level glycopeptide resistance in MRSA. Lancet Infect Dis. 3:67-68.
15. Griffiths, M.A., B.W. Wren, and M. Wilson. 1997. Killing of methicillin-resistant Staphylococcus aureus in vitro using aluminium disulphonated phthalocyanine, a light-activated antimicrobial agent. J. Antimicrob. Chemother. 40:873-876.
16. Gross, S., A. Brandis, L. Chen, V. Rosenbach-Belkin, S. Roehrs, A. Scherz, and Y. Salomon. 1997. Protein-A-mediated targeting of bacteriochlorophyll-IgG to Staphylococcus aureus: a model for enhanced site-specific photocytotoxicity. Photochem. Photobiol. 66:872-878.
17. Hamblin, M.R., D.A. O'Donnell, N. Murthy, C.H. Contag, and T. Hasan. 2002. Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging. Photochem. Photobiol. 75:51-57.
18. Hassan, I.A., P.R. Chadwick, and A.P. Johnson. 2001. Clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to teicoplanin in Northwest England. J. Antimicrob. Chemother. 48:454-455.
19. Hiramatsu, K. 1998. The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan. Am. J Med. 104:7S-10S.
20. Hiramatsu, K. 2003. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis. 1:147-155.
21. Lee, J.C. 2001. Capsule and Vaccine Development. In A.L. Honeyman, H. Friedman, and M. Bendinelli (eds.). Staphylcoccous aureus infection and disease. Kluver Academic/Plenum Publishers, New York, pp. 49-63.
22. Phillips, D. 1997. Chemical mechanisms in photodynamic therapy with phthalocyanines. Progr Reaction Kinet. 22:176-300.
23. Rapp, R.P. 2000. Overview of resistant gram-positive pathogens in the surgical patient. Surg. Infect. (Larchmt.). 1:39-47.
24. Schiotz, P.O., N. Hoiby, and J.B. Hertz. 1979. Cross-reactions between Staphylococcus aureus and fifteen other bacterial species. Acta Pathol. Microbiol. Scand. [B]. 87:329-336.
25. Silva Coimbra, M.V., M.C. Silva-Carvalho, H. Wisplinghoff, G.O. Hall, S. Tallent, S. Wallace, M.B. Edmond, A.M. Figueiredo, and R.P. Wenzel. 2003. Clonal spread of methicillin-resistant Staphylococcus aureus in a large geographic area of the United States. J. Hosp. Infect. 53:103-110.
26. Ugur, A., and O. Ceylan. 2003. Occurrence of resistance to antibiotics, metals, and plasmids in clinical strains of Staphylococcus spp. Arch. Med. Res. 34:130-136.
27. Usacheva, M.N., M.C. Teichert, and M.A. Biel. 2001. Comparison of the methylene blue and toluidine blue photobactericidal efficacy against gram-positive and gram-negative microorganisms. Lasers Surg. Med. 29:165-173.
28. Wainwright, M. 1998. Photodynamic antimicrobial chemotherapy (PACT). J Antimicrob. Chemother. 42:13-28.
29. Wilson, B.C. 2002. Photodynamic therapy for cancer: principles. Can. J. Gastroenterol. 16:393-396.
30. Wilson, M. 1994. Bactericidal effect of laser light and its potential use in the treatment of plaque-related diseases. Int. Dent. J. 44:181-189.
31. Yarmush, M.L., W.P. Thorpe, L. Strong, S.L. Rakestraw, M. Toner, and R.G. Tompkins. 1993. Antibody targeted photolysis. Crit Rev. Ther. Drug Carrier Syst. 10:197-252.
32. Zeina, B., J. Greenman, D. Corry, and W.M. Purcell. 2002. Cytotoxic effects of antimicrobial photodynamic therapy on keratinocytes in vitro. Br. J. Dermatol. 146:568-573.
33. Zeina, B., J. Greenman, W.M. Purcell, and B. Das. 2001. Killing of cutaneous microbial species by photodynamic therapy. Br. J. Dermatol. 144:274-278.